Acute inflammatory and anabolic systemic responses to peak and constant-work-rate exercise bout in hospitalized patients with COPD

International Journal of COPD

Volumn 2, Issue 4, 2007, Pages 575-583

  Spruit, Martijn A ^a,b   Troosters, Thierry ^a,b   Gosselink, Rik ^a,b   Kasran, Ahmad ^b   Decramer, Marc ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Creactive protein; Insulin like growth factor 1; Interleukin 6; Interleukin 8

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BELGIUM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFLAMMATION; LENGTH OF STAY; MALE; MUSCLE METABOLISM; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYMPTOM; SYSTEMIC DISEASE; UNIVERSITY HOSPITAL;

AGED; BELGIUM; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; EXERCISE TOLERANCE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 38049130485     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Anon. 1997. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 277:925-6.
2. Altman DG, Gore SM, Gardner MJ, et al. 1983. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed), 286:1489-93.
3. Anthonisen NR, Manfreda J, Warren CP, et al. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 106:196-204.
4. Bamman MM, Shipp JR, Jiang J, et al. 2001. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab, 280:13383-90.
5. Bernard S, Whittom F, LeBlanc P, et al. 1999. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 159:896-901.
6. Borg GAV. 1998. Borg's perceived exertion and pain scales, 1st edn. Human Kinetics, Champaign, IL.
7. Bourjeily-Habr G, Rochester CL, Palermo F, et al. 2002. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax, 57:1045-9.
8. Cappon J, Brasel JA, Mohan S, et al. 1994. Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol, 76:2490-6.
9. Casaburi R, Patessio A, loli F, et al. 1991. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis, 143:9-18.
10. Cook EB, Stahl JL, Lowe L, et al. 2001. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs non-allergics. J Immunol Methods, 254:109-18.
11. Coppoolse R, Schols AM, Baarends EM, et al. 1999. Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J, 14:258-63.
12. Couillard A, Koechlin C, Cristol JP, et al. 2002. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J, 20:1123-9.
13. Couillard. A, Maltais F, Saey D, et al. 2003. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in COPD patients. Am J Respir Crit Care Med.
14. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, et al. 2000. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 162:1239-45.
15. Dall R, Longobardi S, Ehrnborg C, et al. 2000. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab, 85:4193-200.
16. Debigare R, Cote CH, Maltais F. 2001. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med, 164:1712-17.
17. Debigare R, Marquis K, Cote CH, et al. 2003. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest, 124:83-9.
18. Dentener MA, Creutzberg EC, Schols AM, et al. 2001. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax, 56:721-6.
19. Ehrnborg C, Lange KH, Dall R, et al. 2003. The growth hormone/ insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab, 88:394-401.
20. Eid AA, lonescu AA, Nixon LS, et al. 2001. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164:1414-18.
21. Engelen MP, Wouters EF, Deutz NE, et al. 2001. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 163:859-64.
22. Fernandez-Celemin L, Pasko N, Blomart V, et al. 2002. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab, 283:E1279-90.
23. Gan WQ, Man SF, Senthilselvan A, et al. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax, 59:574-80.
24. Gosselink R, Troosters T, Decramer M. 1996. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med, 153:976-80.
25. Hornum M, Cooper DM, Brasel JA, et al. 1997. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women. J Appl Physiol, 82:1946-51.
26. Jones NL, Makrides L, Hitchcock C, et al. 1985. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis, 131:700-8.
27. Maltais F, LeBlanc P, Jobin J, et al. 1997. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 155:555-61.
28. Maltais F, LeBlanc P, Simard C, et al. 1996. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 154:442-7.
29. Man WD, Polkey MI, Donaldson N, et al. 2004. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ, 329:1209.
30. Neder JA, Jones PW, Nery LE, et al. 2000. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med, 162:497-504.
31. Neder JA, Sword D, Ward SA, et al. 2002. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax, 57:333-7.
32. Nemet D, Oh Y, Kim HS, et al. 2002. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics, 110:681-9.
33. Nieman DC, Davis JM, Henson DA, et al. 2003. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol, 94:1917-25.
34. Ostrowski K, Rohde T, Asp S, et al. 2001. Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol, 84:244-5.
35. Ostrowski K, Schjerling P, Pedersen BK. 2000. Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol, 83:512-15.
36. Rabinovich RA, Figueras M, Ardite E, et al. 2003. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J, 21:789-94.
37. Rodriguez-Roisin R. 2000. Toward a consensus definition for COPD exacerbations. Chest, 117:(5 Suppl 2):398S-401S.
38. Schwarz AJ, Brasel JA, Hintz RL, et al. 1996. Acute effect of brieflow- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab, 81:3492-7.
39. Simpson K, Killian K, McCartney N, et al. 1992. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax, 47:70-5.
40. Spruit MA, Gosselink R, Troosters T, et al. 2002. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J, 19:1072-8.
41. Spruit MA, Gosselink R, Troosters T, et al. 2003. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax, 58:752-6.
42. Spruit MA, Troosters T, Trappenburg JCA, et al. 2004. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Couns, 52:243-8.
43. Tirakitsoontorn P, Nussbaum E, Moser C, et al. 2001. Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med, 164:1432-7.
44. Troosters T, Gosselink R, Decramer M. 2000. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med, 109:207-12.
45. van't Hul A, Gosselink R, Kwakkel G. 2003. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J Cardiopulm Rehabil, 23:143-50.
46. van den Berghe G, Baxter RC, Weekers F, et al. 2000. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab, 85:183-92.
47. Van Helvoort HA, Heijdra YF, Thijs HM, et al. 2006. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc, 38:1543-52.
48. Vogiatzis I, Nanas S, Roussos C. 2002. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J, 20:12-19.
49. Wedzicha JA, Seemungal TA, MacCallum PK, et al. 2000. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost, 84:210-15.